Cai Y - Search Results

1

Neoadjuvant versus adjuvant imatinib in primary localized gastrointestinal stromal tumor.

Ling J, Shi L, Cheng X, Fu Y, Lin Z, Zhao Y, Li Z, Zhang J, Hu H, Cai Y, Deng Y. Ling J, et al. Among authors: cai y. J Gastrointest Oncol. 2023 Feb 28;14(1):73-84. doi: 10.21037/jgo-22-931. Epub 2023 Jan 10. J Gastrointest Oncol. 2023. PMID: 36915468 Free PMC article.

2

[Prophylaxis and treatment of modified BFM-90 regimen for lymphoblastic lymphoma in children and adolescents accompanied with infection].

Zhen ZJ, Xia Y, Ling JY, Tong GL, Lin L, Cai Y, Sun XF. Zhen ZJ, et al. Among authors: cai y. Ai Zheng. 2009 Jul;28(7):718-24. doi: 10.5732/cjc.008.10673. Ai Zheng. 2009. PMID: 19624898 Free article. Chinese.

3

Significance of myeloid antigen expression in precursor T lymphoblastic lymphoma.

Cai Y, Sun XF, Yan SL, Zhen ZJ, Xia Y, Ling JY. Cai Y, et al. Chin J Cancer. 2010 Mar;29(3):312-6. doi: 10.5732/cjc.009.10552. Chin J Cancer. 2010. PMID: 20193116 Free article.

4

Clinical analysis of thymic regrowth following chemotherapy in children and adolescents with malignant lymphoma.

Zhen Z, Sun X, Xia Y, Ling J, Cai Y, Wang J, Guan Z. Zhen Z, et al. Among authors: cai y. Jpn J Clin Oncol. 2010 Dec;40(12):1128-34. doi: 10.1093/jjco/hyq149. Epub 2010 Aug 7. Jpn J Clin Oncol. 2010. PMID: 20693549

5

Impact of HLA-E gene polymorphism on HLA-E expression in tumor cells and prognosis in patients with stage III colorectal cancer.

Zhen ZJ, Ling JY, Cai Y, Luo WB, He YJ. Zhen ZJ, et al. Among authors: cai y. Med Oncol. 2013 Mar;30(1):482. doi: 10.1007/s12032-013-0482-2. Epub 2013 Feb 3. Med Oncol. 2013. PMID: 23377987

6

[Safety and efficacy analysis on modified FOLFOXIRI as first-line treatment for advanced colorectal cancer in China-single center experience].

Cai Y, Hu H, Wang W, Cao T, Deng Y. Cai Y, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2014 Nov;17(11):1081-6. Zhonghua Wei Chang Wai Ke Za Zhi. 2014. PMID: 25421765 Chinese.

7

Visceral adipose tissue and the risk of colorectal adenomas: a meta-analysis of observational studies.

Hu H, Cai Y, Huang J, Zhang J, Deng Y. Hu H, et al. Among authors: cai y. Eur J Cancer Prev. 2015 Nov;24(6):462-9. doi: 10.1097/CEJ.0000000000000113. Eur J Cancer Prev. 2015. PMID: 25494291

8

KRAS as a predictor of poor prognosis and benefit from postoperative FOLFOX chemotherapy in patients with stage II and III colorectal cancer.

Deng Y, Wang L, Tan S, Kim GP, Dou R, Chen D, Cai Y, Fu X, Wang L, Zhu J, Wang J. Deng Y, et al. Among authors: cai y. Mol Oncol. 2015 Aug;9(7):1341-7. doi: 10.1016/j.molonc.2015.03.006. Epub 2015 Mar 27. Mol Oncol. 2015. PMID: 25864038 Free PMC article.

9

Survival of patients with KRAS wild-type metastatic colorectal cancer is identical after sequential treatment with cetuximab and bevacizumab regardless of the sequence - A retrospective single-center study.

Deng Y, Cai Y, Lin J, Jiang L, Hu H. Deng Y, et al. Among authors: cai y. Gastroenterol Rep (Oxf). 2015 Nov;3(4):339-43. doi: 10.1093/gastro/gov051. Epub 2015 Oct 13. Gastroenterol Rep (Oxf). 2015. PMID: 26468218 Free PMC article.

10

High SLFN11 expression predicts better survival for patients with KRAS exon 2 wild type colorectal cancer after treated with adjuvant oxaliplatin-based treatment.

Deng Y, Cai Y, Huang Y, Yang Z, Bai Y, Liu Y, Deng X, Wang J. Deng Y, et al. Among authors: cai y. BMC Cancer. 2015 Nov 2;15:833. doi: 10.1186/s12885-015-1840-6. BMC Cancer. 2015. PMID: 26525741 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,697 results

Search Page

Filters